TY - JOUR
T1 - Idiopathic anaphylaxis
AU - Grammer, Leslie
AU - Harris, Kathleen E.
PY - 2002/11
Y1 - 2002/11
N2 - Background: Idiopathic anaphylaxis (IA) is a life-threatening disease. It is also a disease that is very often misdiagnosed. Before a diagnosis is established, the patient care costs can be exorbitant with regards to such things as emergency department visits and laboratory tests. In order to allow more patients to benefit from appropriate treatment, the medical community still needs to be better informed regarding this under-diagnosed disease. Method / data base: A review of the literature. Results and conclusion: Although the understanding of the initiating pathophysiology of IA is limited, it has proven to be a steroid responsive disease. It is also a disease that has a good prognosis for remission, in excess of 80%, with appropriate therapy.
AB - Background: Idiopathic anaphylaxis (IA) is a life-threatening disease. It is also a disease that is very often misdiagnosed. Before a diagnosis is established, the patient care costs can be exorbitant with regards to such things as emergency department visits and laboratory tests. In order to allow more patients to benefit from appropriate treatment, the medical community still needs to be better informed regarding this under-diagnosed disease. Method / data base: A review of the literature. Results and conclusion: Although the understanding of the initiating pathophysiology of IA is limited, it has proven to be a steroid responsive disease. It is also a disease that has a good prognosis for remission, in excess of 80%, with appropriate therapy.
UR - http://www.scopus.com/inward/record.url?scp=0036876939&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036876939&partnerID=8YFLogxK
U2 - 10.1027/0838-1925.14.6.246
DO - 10.1027/0838-1925.14.6.246
M3 - Article
AN - SCOPUS:0036876939
SN - 0838-1925
VL - 14
SP - 246
EP - 252
JO - Allergy and Clinical Immunology International
JF - Allergy and Clinical Immunology International
IS - 6
ER -